Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) has a beta value of -0.09 and has seen 4.48 million shares traded in the last trading session. The company, currently valued at $82.24M, closed the last trade at $2.61 per share which meant it lost -$0.16 on the day or -5.78% during that session. The RVPH stock price is -117.24% off its 52-week high price of $5.67 and 77.01% above the 52-week low of $0.60. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.06 million shares traded. The 3-month trading volume is 1.11 million shares.
The consensus among analysts is that Reviva Pharmaceuticals Holdings Inc (RVPH) is Buy stock at the moment, with a recommendation rating of 1.67. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.23.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Sporting -5.78% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RVPH stock price touched $2.61 or saw a rise of 39.02%. Year-to-date, Reviva Pharmaceuticals Holdings Inc shares have moved -49.32%, while the 5-day performance has seen it change 58.18%. Over the past 30 days, the shares of Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) have changed 108.80%. Short interest in the company has seen 5.3 million shares shorted with days to cover at 19.04.
Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts
Figures show that Reviva Pharmaceuticals Holdings Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 78.77% over the past 6 months, with this year growth rate of 38.79%, compared to 16.40% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Insiders own 14.79% of the company shares, while shares held by institutions stand at 30.07% with a share float percentage of 35.28%. Investors are also buoyed by the number of investors in a company, with Reviva Pharmaceuticals Holdings Inc having a total of 35.0 institutions that hold shares in the company. The top two institutional holders are WOODLINE PARTNERS LP with over 1.59 million shares worth more than $2.04 million. As of 2024-06-30, WOODLINE PARTNERS LP held 6.6273% of shares outstanding.
The other major institutional holder is MILLENNIUM MANAGEMENT LLC, with the holding of over 1.24 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.59 million and represent 5.1656% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 2.09% shares in the company for having 700.44 shares of worth $1.83 million while later fund manager owns 312.3 shares of worth $0.82 million as of Sep 30, 2024 , which makes it owner of about 0.93% of company’s outstanding stock.
